Years later I learned the U.S. Preventative Services Task Force (USPSTF) issued definitive guidelines in 2012 not to screen for prostate cancer. It said knowing about prostate can ...

One of two of Opthea's phase III trials for a common eye disease has failed to meet its objectives, casting doubts on the ...

The prostate gland, though small in size, plays a significant role in men’s health. Situated just below the bladder and in ...

Discover how micro-ultrasound could revolutionise prostate cancer diagnosis. Learn about this game-changing technology.

A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...

Men with a family history of prostate cancer should begin screenings at age 40 or even earlier, especially if multiple close relatives have been affected. Research consistently indicates that African ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the ...

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...

MGC026, which is a TOP1i-based ADC, is undergoing a phase 1 dose-escalation study in patients with advanced solid tumors. The ...

Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.

Men who consistently avoid prostate cancer screening appointments face a much higher risk of dying from the disease, ...